FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166408911> ?p ?o ?g. }

• W3166408911 abstract "Spontaneous remission in acute lymphoblastic leukemia (ALL) is a rare phenomenon, which typically involves a pattern of feverish or septic disease followed by quick but mostly transient remission. We report on two male patients (46-year-old (pt. 1) and 19-year-old (pt. 2)) with CD20 positive, BCR-ABL negative common B-ALL. Patient 1 had received dexamethasone and cyclophosphamide (1.2 g) as a prephase therapy, followed by rituximab and a cumulative dose of 200 mg daunorubicin combined with 2 mg vincristine as an induction therapy. Patient 2 was treated with a reduced therapy regimen (Vincristine 1 mg, dexamethasone and 80 mg daunorubicin, 12-month mercaptopurine maintenance) due to (alcohol-related) toxic liver failure and pontine myelinolysis. Both patients developed severe septic disease just few days into induction treatment. Patient 1 suffered from pulmonary mycosis, which had to be resected eventually. Histological work-up revealed invasive mucor mycosis. Patient 2 presented with elevated serum aspergillus antigen and radiographic pulmonary lesions, indicative of pulmonary mycosis. In both patients, chemotherapy had to be interrupted and could not be resumed. Both patients recovered under broad antimicrobial, antifungal and prophylactic antiviral therapy and achieved molecular complete remission. At data cut-off remissions had been on-going for 34 months (pt. 1) and 8 years (pt. 2). Short-term, reduced intensity induction chemotherapy accompanied by severe fungal infections was followed by long-lasting continuous complete remissions in ALL. Thus, we hypothesize that infection-associated immunogenic responses may not only prevent early relapse of ALL but could also eradicate minimal residual disease. The effects of combined cytotoxic therapy and severe infection may also be mimicked by biomodulatory treatment strategies aiming at reorganizing pathologically altered cellular signaling networks. This could reduce toxicity and comorbidity in adult patients requiring leukemia treatment. Therefore, these two cases should encourage systematic studies on how leukemia stroma interaction can be harnessed to achieve long lasting control of ALL." @default.
• W3166408911 created "2021-06-22" @default.
• W3166408911 creator A5001678596 @default.
• W3166408911 creator A5031218116 @default.
• W3166408911 creator A5040663053 @default.
• W3166408911 creator A5041945240 @default.
• W3166408911 creator A5043156173 @default.
• W3166408911 creator A5054985649 @default.
• W3166408911 creator A5082924805 @default.
• W3166408911 creator A5087467494 @default.
• W3166408911 date "2021-06-02" @default.
• W3166408911 modified "2023-09-30" @default.
• W3166408911 title "Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy" @default.
• W3166408911 cites W1575122600 @default.
• W3166408911 cites W1911271782 @default.
• W3166408911 cites W1993491016 @default.
• W3166408911 cites W1998660089 @default.
• W3166408911 cites W2001192978 @default.
• W3166408911 cites W2002798599 @default.
• W3166408911 cites W2006601633 @default.
• W3166408911 cites W2014315961 @default.
• W3166408911 cites W2025488184 @default.
• W3166408911 cites W2062126843 @default.
• W3166408911 cites W2062191416 @default.
• W3166408911 cites W2105683217 @default.
• W3166408911 cites W2106229108 @default.
• W3166408911 cites W2120211786 @default.
• W3166408911 cites W2124097936 @default.
• W3166408911 cites W2170307392 @default.
• W3166408911 cites W2526134968 @default.
• W3166408911 cites W2618639283 @default.
• W3166408911 cites W2766179151 @default.
• W3166408911 cites W2783037826 @default.
• W3166408911 cites W2800982521 @default.
• W3166408911 cites W2886389978 @default.
• W3166408911 cites W2900379337 @default.
• W3166408911 cites W2903476493 @default.
• W3166408911 cites W2973649648 @default.
• W3166408911 cites W2989878150 @default.
• W3166408911 cites W3000342395 @default.
• W3166408911 cites W4211046582 @default.
• W3166408911 cites W4312036571 @default.
• W3166408911 cites W60055175 @default.
• W3166408911 doi "https://doi.org/10.3389/fphar.2021.599552" @default.
• W3166408911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8206565" @default.
• W3166408911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34149402" @default.
• W3166408911 hasPublicationYear "2021" @default.
• W3166408911 type Work @default.
• W3166408911 sameAs 3166408911 @default.
• W3166408911 citedByCount "4" @default.
• W3166408911 countsByYear W31664089112022 @default.
• W3166408911 countsByYear W31664089112023 @default.
• W3166408911 crossrefType "journal-article" @default.
• W3166408911 hasAuthorship W3166408911A5001678596 @default.
• W3166408911 hasAuthorship W3166408911A5031218116 @default.
• W3166408911 hasAuthorship W3166408911A5040663053 @default.
• W3166408911 hasAuthorship W3166408911A5041945240 @default.
• W3166408911 hasAuthorship W3166408911A5043156173 @default.
• W3166408911 hasAuthorship W3166408911A5054985649 @default.
• W3166408911 hasAuthorship W3166408911A5082924805 @default.
• W3166408911 hasAuthorship W3166408911A5087467494 @default.
• W3166408911 hasBestOaLocation W31664089111 @default.
• W3166408911 hasConcept C126322002 @default.
• W3166408911 hasConcept C141071460 @default.
• W3166408911 hasConcept C2776694085 @default.
• W3166408911 hasConcept C2776755627 @default.
• W3166408911 hasConcept C2778880498 @default.
• W3166408911 hasConcept C2779338263 @default.
• W3166408911 hasConcept C2779429289 @default.
• W3166408911 hasConcept C2780401358 @default.
• W3166408911 hasConcept C2780653079 @default.
• W3166408911 hasConcept C71924100 @default.
• W3166408911 hasConcept C90924648 @default.
• W3166408911 hasConceptScore W3166408911C126322002 @default.
• W3166408911 hasConceptScore W3166408911C141071460 @default.
• W3166408911 hasConceptScore W3166408911C2776694085 @default.
• W3166408911 hasConceptScore W3166408911C2776755627 @default.
• W3166408911 hasConceptScore W3166408911C2778880498 @default.
• W3166408911 hasConceptScore W3166408911C2779338263 @default.
• W3166408911 hasConceptScore W3166408911C2779429289 @default.
• W3166408911 hasConceptScore W3166408911C2780401358 @default.
• W3166408911 hasConceptScore W3166408911C2780653079 @default.
• W3166408911 hasConceptScore W3166408911C71924100 @default.
• W3166408911 hasConceptScore W3166408911C90924648 @default.
• W3166408911 hasLocation W31664089111 @default.
• W3166408911 hasLocation W31664089112 @default.
• W3166408911 hasLocation W31664089113 @default.
• W3166408911 hasOpenAccess W3166408911 @default.
• W3166408911 hasPrimaryLocation W31664089111 @default.
• W3166408911 hasRelatedWork W115168992 @default.
• W3166408911 hasRelatedWork W1973158710 @default.
• W3166408911 hasRelatedWork W1998397384 @default.
• W3166408911 hasRelatedWork W2017047848 @default.
• W3166408911 hasRelatedWork W2036726143 @default.
• W3166408911 hasRelatedWork W2049808065 @default.
• W3166408911 hasRelatedWork W2060816095 @default.
• W3166408911 hasRelatedWork W2293389072 @default.
• W3166408911 hasRelatedWork W4206209534 @default.
• W3166408911 hasRelatedWork W4236815493 @default.
• W3166408911 hasVolume "12" @default.

• next